Redcare Pharmacy NV (ETR:RDC)
Germany · Delayed Price · Currency is EUR 59.55
+2.45 (4.29%)
Sep 4, 2026, 5:35 PM CET
Redcare Pharmacy NV Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,225 | 1,324 | 2,679 | 2,395 | 798 | 2,050 | |
Market Cap Growth | -17.70% | -50.57% | 11.86% | 200.06% | -61.07% | -22.87% |
Enterprise Value | 1,479 | 1,465 | 2,742 | 2,508 | 840 | 1,990 |
Last Close Price | 59.55 | 65.10 | 131.70 | 131.60 | 44.11 | 113.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 141.05 | 257.95 | 257.95 | - | - | - |
PS Ratio | 0.38 | 0.45 | 1.13 | 1.33 | 0.66 | 1.93 |
PB Ratio | 2.58 | 2.76 | 5.25 | 4.34 | 2.25 | 4.93 |
P/TBV Ratio | 17.56 | 20.16 | 36.85 | 25.46 | 12.16 | 12.98 |
P/FCF Ratio | - | - | 199.93 | 43.53 | - | - |
P/OCF Ratio | - | 42.72 | 121.23 | 38.97 | - | 176.21 |
PEG Ratio | - | 28.81 | 28.81 | 28.81 | 28.81 | 28.81 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.46 | 0.50 | 1.16 | 1.40 | 0.70 | 1.88 |
EV/EBITDA Ratio | 55.19 | 732.56 | - | 173.30 | - | - |
EV/FCF Ratio | - | - | 204.64 | 45.59 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.75 | 0.87 | 0.49 | 0.44 | 0.66 | 0.55 |
Debt / EBITDA Ratio | 13.64 | 45.28 | - | 11.75 | - | - |
Debt / FCF Ratio | - | - | 18.45 | 4.43 | - | - |
Net Debt / Equity Ratio | 0.50 | 0.45 | 0.14 | 0.07 | 0.16 | -0.13 |
Net Debt / EBITDA Ratio | 12.54 | 106.55 | -4.10 | 2.74 | -1.61 | 2.59 |
Net Debt / FCF Ratio | -3.28 | -4.41 | 5.20 | 0.72 | -1.28 | 25.65 |
Asset Turnover | 2.69 | 2.65 | 2.34 | 2.05 | 1.59 | 1.61 |
Inventory Turnover | 13.46 | 12.39 | 12.60 | 11.54 | 8.89 | 8.92 |
Quick Ratio | 0.78 | 0.89 | 1.21 | 1.45 | 1.85 | 2.58 |
Current Ratio | 1.59 | 1.55 | 2.00 | 2.23 | 2.88 | 3.49 |
Return on Equity (ROE) | -8.67% | -7.97% | -8.74% | -2.56% | -20.17% | -17.65% |
Return on Assets (ROA) | -0.16% | -1.13% | -2.41% | -0.27% | -3.90% | -3.05% |
Return on Capital Employed (ROCE) | -0.40% | -2.50% | -5.20% | -0.50% | -7.70% | -4.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.43% | -2.85% | -1.70% | -0.50% | -9.73% | -3.62% |
FCF Yield | -5.87% | -3.65% | 0.50% | 2.30% | -5.35% | -0.11% |
Buyback Yield / Dilution | -0.09% | -0.27% | -4.24% | -6.97% | -0.57% | -24.37% |